Cashu Markets
Cashu
Markets
  • Terminal
  • Stocks
  • Spotlight
  • News
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. TIVC

Market Cap: $313.06K

TI

Tivic Health Systems, Inc.

TIVC
NASDAQUSD
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

StocksAbout Cashu MarketsContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

–
USD
–(–)

Open

$0.48

Prev. Close

$0.286

High

$0.50

Low

$0.48

Company Profile

Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company’s pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was incorporated in 2016 and is based in San Antonio, Texas.

CEOMichael Kevin Handley
Sector

Recently from Cashu

Tivic Health Systems Acquires Entolimod, Expanding Therapeutics Pipeline and Market Potential

Tivic Health Systems Expands Therapeutics Pipeline with Entolimod Acquisition Tivic Health Systems, Inc. has made a significant leap in its transition from a direct-to-consumer model to a diversified…

Cashu Markets·over 1 year ago

Tivic Health Systems Innovates for Growth Amid Financial Challenges and Leadership Changes

Tivic Health Systems Charts Future Growth with Strategic Innovations Tivic Health Systems, Inc., a pioneering company in the bioelectronic medicine sector, recently unveils its financial results for t…

Cashu Markets·over 1 year ago

Tivic Health Systems Advances Non-Invasive Vagus Nerve Stimulation Research and Market Strategy

Tivic Health Systems Advances Non-Invasive Vagus Nerve Stimulation Research Tivic Health® Systems, Inc., a pioneering health tech company in bioelectronic medicine, announces the completion of full en…

Cashu Markets·over 1 year ago

Tivic Health Secures Patent Validation, Advancing Bioelectronic Medicine for Chronic Sinus Treatment

Tivic Health's Patent Validation Marks a Strategic Advancement in Bioelectronic Medicine Tivic Health Systems, Inc., a pioneering player in the bioelectronic medicine sector, announces the validation…

Cashu Markets·over 1 year ago
Healthcare
IndustryMedical - Devices
Employees52
IPO DateNov 11, 2021
ExchangeNASDAQ
Exchange NameNASDAQ
CurrencyUSD
Headquarters & Contact
Address47685 Lakeview Blvd.
City / State / ZIPFremont, CA, 94538
CountryUnited States
Phone888 276 6888
Websitehttps://tivichealth.com